Antimicrobial Susceptibility Testing Market: Growth Opportunity | Merck, Bio-Rad Laboratories Inc, bioMérieux S.A., Becton

According to the report, the global antimicrobial susceptibility testing market size is expected to reach $4.95 Billion by 2028 growing at the CAGR of 5.83% from 2021 to 2028. Owing to a growth in demand for automated devices such as AST cards, AST panels, and high-tech automated systems that provide higher accuracy, faster processing, and enhanced workflow, the antimicrobial susceptibility testing market is attracting interest from healthcare firms. This leads to an increase in the usage of automated systems in pharmaceutical and biotechnology companies, indicating that the industry had a lot more potential. This growth is attributed to the market's growth may be hampered by the cost of automated ID/AST systems is very high. However, Antimicrobial resistance and its control in emerging markets and awareness initiatives create significant growth opportunities for the market during the forecast period.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005432
The recently published research report on Global Antimicrobial Susceptibility Testing Market by Evolve Business Intelligence examines the industry in the context of major market aspects including market size & forecast, market shares in terms of revenues and volume, key players, and SWOT analysis. The market is analyzed based on 4 separate indications in the market dynamic chapter: Drivers, Restraints, Key Trends, and Challenges. The total sum of these sections will help you understand what strategies will be best to adopt in order to prosper through this industry over a few short years. The quantitative analysis includes our actual findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.

The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the Antimicrobial Susceptibility Testing market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

The New Normal
As businesses recover from the COVID-19 pandemic, they have a new set of priorities to cope with. Throughout this crisis, they were forced to deal with shifting situations and often fell short of their ultimate goals. Now that a cure has been found and the pandemic is dying down, they will need to recuperate from this epidemic by setting forth new objectives to succeed in the future.

In terms of COVID 19 impact, the Antimicrobial Susceptibility Testing market report also includes the following data points:
• COVID19 Impact on Antimicrobial Susceptibility Testing market size
• End-User/Industry/Application Trend, and Preferences
• Government Policies/Regulatory Framework
• Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
• Opportunity in the Antimicrobial Susceptibility Testing market

Buy Latest Copy of Report Now at Higher Discount: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005432

Key Players
Some of the major Antimicrobial Susceptibility Testing players holding a high market share include Merck, Bio-Rad Laboratories Inc, bioMérieux S.A., Becton. These players use new product development as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
• Thermo Fisher Scientific Inc
• Merck
• Bio-Rad Laboratories, Inc
• bioMérieux S.A.
• Becton
• MERLIN Diagnostika
• Accelerate Diagnostics, Inc
• Alifax S.r.l.
• Creative Diagnostics
• Synbiosis

Segmental Analysis
Market Segment By Product Type with focus on market share, consumption trend, and growth rate of Antimicrobial Susceptibility Testing Market:
o Instruments
o Consumables & Accessories
o Services & Software
o Others

Market Segment By Size with focus on market share, consumption trend, and growth rate of Antimicrobial Susceptibility Testing Market:
o Clinical Diagnostics
o Drug Discovery and Development
o Epidemiology

For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005432

Global Antimicrobial Susceptibility Testing Geographic Coverage:
• North America
o US
o Canada
o Mexico

• Europe
o UK
o Germany
o France
o Italy
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o South Korea
o Rest of Asia Pacific

• Rest of the World
o South America
o Middle East & Africa

In 2020, North America had the majority of the worldwide antimicrobial susceptibility testing market share, and this trend is expected to continue during the forecast period. This is due to an increase in antibiotic resistance, the presence of significant players, increased healthcare spending, technological improvements, and increased government actions in the region.

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.